Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.…
Clarivate Reveals Highly Cited Researchers 2026 List
Clarivate (NYSE: CLVT) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Information Technology Services industry, part of the Technology sector, and reports about 12,000 employees.
The shares were at 2.010 USD on 20 November 2026, down 40.4% over 52 weeks. Its 52-week range is 1.420 USD to 3.870 USD: the price is 48.1% below the high and 41.5% above the low.
Its market capitalisation is 1.29B USD.
Clarivate reports return on equity of -4.2%, an operating margin of 7.6% and revenue down 9.2% year over year.
Its debt exceeds its cash by 3.94B USD, a debt-to-equity ratio of 0.92. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 8 analysts cover the stock, with an average rating of Hold; their mean price target of 3.006 USD is 49.6% above the current price. The next earnings report is expected on 24 February 2027.